The global antithrombotic drugs market is projected to grow at a CAGR of around 7.5% during the forecast period. The market growth is attributed to various factors such as the growing incidence and prevalence of blood-related diseases such as deep vein thrombosis, pulmonary embolism, strokes, and heart attack. Increasing geriatric population and obesity is the main cause of clotting which lead to the growth of the market.
Get Free Sample link @ https://www.omrglobal.com/request-sample/anthithrombotic-drugs-market
However, some factors are expected to restrain the market growth that includes lack of health infrastructure in low economic countries, high cost of medicines, and side effects of the treatment. However, promotional initiatives and campaigns to raise awareness about the problems caused by a blood clot and their treatments, increasing healthcare spending, and extensive collaborations between market players are the factors that are creating growth opportunities for the antithrombotic drugs market across the globe.
A full report of Global Antithrombotic Drugs Market available @ https://www.omrglobal.com/industry-reports/anthithrombotic-drugs-market
- Market Coverage
- Market number available for – 2022-2028
- Base year- 2021
- Forecast period- 2022-2028
- Segment Covered- By Source, By Product Type, By Applications
- Competitive Landscape- Archer Daniels Midland Co., Ingredion Inc., Kerry Group Plc, Cargill Inc., and others
Market Segmentation
Antithrombotic Drugs Market By Route Of Administration
- Oral
- Parenteral
Antithrombotic Drugs Market By Application
- Deep Vein Thrombosis
- Atrial Fibrillation
- Pulmonary Embolism
- Others
Regional Analysis
- North America
- United States
- Canada
- Europe
- UK
- Germany
- Italy
- Spain
- France
- Rest of Europe
- Asia-Pacific
- China
- India
- Japan
- Rest of Asia-Pacific
- Rest of the World
Company Profiles
- Aspen Holdings
- Athersys, Inc.
- Bayer AG
- Boehringer Ingelheim GmbH
- Bristol-Myers Squibb Co.
- Daiichi Sankyo Co.
- Eli Lilly and Company
- GlaxoSmithKline Plc
- Inari Medical, Inc.
- Microbix Biosystems Inc.
- Pfizer Inc.
- Portola Pharmaceuticals, Inc.
- Sanofi S.A.
- Teva Pharmaceutical Industries Ltd.
The Report Covers
- Market value data analysis of 2020 and forecast to 2027.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global antithrombotic drugs market. Based on the availability of data, information related to new Drug type launches, and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/anthithrombotic-drugs-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 780-304-0404
